A leading expert in pediatric oncology/hematology, Dr. Kirov serves as CHOC Children’s Specialists director of oncology, as well as the director of the lymphoma program and recurrent/refractory cancer program.
On the forefront of innovative research, Dr. Kirov’s clinical research interests include Hodgkin’s and Non-Hodgkin’s lymphomas, leukemia, stem cell transplantation and innovative therapies for patients with recurrent cancer. He is a principal investigator for Children’s Oncology Group (COG) Phase I studies at CHOC Children’s Hospital, and co-investigator in all ongoing COG studies. Dr. Kirov is a principal investigator in several pharmaceutical industry sponsored clinical studies in the areas of chronic myeloid leukemia and stem cell transplantation. A prolific and respected author, Dr. Kirov has written many publications and has been published in a number of journals including Bone Marrow Transplant and the Journal of Pediatric Hematology/Oncology.
Dedicated to clinical excellence, Dr. Kirov is board certified in pediatric hematology/oncology. He earned his medical degree from the Medical Academy in Sofia, Bulgaria. He completed his residency training and fellowship in pediatric and adult hematology in Bulgaria where he went on to become a leading pediatric hematologist/oncologist for more than 12 years. When Dr. Kirov relocated to the United States, he became a visiting fellow in the bone marrow transplant program at the Johns Hopkins Hospital Oncology Center. He then went on to complete a residency in pediatrics at Westchester County Medical Center, New York and postdoctoral fellowship in pediatric hematology/oncology at CHOC Children’s.